AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 169 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $932,000 | -7.4% | 223,514 | +6.3% | 0.00% | -100.0% |
| Q4 2021 | $1,007,000 | -22.4% | 210,284 | -13.5% | 0.00% | 0.0% |
| Q3 2021 | $1,298,000 | +27.3% | 243,047 | +22.0% | 0.00% | 0.0% |
| Q2 2021 | $1,020,000 | -54.5% | 199,239 | -40.3% | 0.00% | 0.0% |
| Q1 2021 | $2,244,000 | +253.9% | 333,498 | +140.5% | 0.00% | – |
| Q4 2020 | $634,000 | -14.2% | 138,647 | -27.3% | 0.00% | -100.0% |
| Q3 2020 | $739,000 | -30.7% | 190,584 | -14.9% | 0.00% | 0.0% |
| Q2 2020 | $1,066,000 | +29.4% | 224,040 | -5.4% | 0.00% | 0.0% |
| Q1 2020 | $824,000 | -15.4% | 236,760 | +17.1% | 0.00% | 0.0% |
| Q4 2019 | $974,000 | +202.5% | 202,149 | +82.2% | 0.00% | – |
| Q3 2019 | $322,000 | +51.9% | 110,950 | +275.8% | 0.00% | – |
| Q2 2019 | $212,000 | -82.1% | 29,520 | -64.7% | 0.00% | -100.0% |
| Q1 2019 | $1,185,000 | -40.7% | 83,659 | -43.3% | 0.00% | -50.0% |
| Q4 2018 | $1,997,000 | -52.5% | 147,623 | -22.2% | 0.00% | -50.0% |
| Q3 2018 | $4,208,000 | +9.1% | 189,649 | -19.3% | 0.00% | 0.0% |
| Q2 2018 | $3,856,000 | – | 235,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |